UBS raised the firm’s price target on Halliburton (HAL) to $21 from $20 and keeps a Neutral rating on the shares. Persistent commodity headwinds continue to dampen upside potential, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HAL:
- Halliburton initiated with a Buy at Melius Research
- ConocoPhillips awards Halliburton contract to deliver well stimulation services
- Halliburton’s Strategic Resilience and Growth Potential Amidst Market Challenges
- Halliburton weakness a buying opportunity, says Argus
- Halliburton downgraded to Neutral from Overweight at Piper Sandler